NDC 0220-3053

Lapis albus

Calcium Hexafluorosilicate

Lapis albus is a Oral Pellet in the Human Prescription Drug category. It is labeled and distributed by Boiron. The primary component is Calcium Hexafluorosilicate.

Product ID0220-3053_68f897e3-b392-1cca-e053-2a91aa0ae21d
NDC0220-3053
Product TypeHuman Prescription Drug
Proprietary NameLapis albus
Generic NameCalcium Hexafluorosilicate
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date1983-03-03
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameBoiron
Substance NameCALCIUM HEXAFLUOROSILICATE
Active Ingredient Strength6 [hp_C]/6[hp_C]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 0220-3053-41

6 [hp_C] in 1 TUBE (0220-3053-41)
Marketing Start Date1983-03-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0220-3053-41 [00220305341]

Lapis albus PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1983-03-03

Drug Details

Active Ingredients

IngredientStrength
CALCIUM HEXAFLUOROSILICATE6 [hp_C]/6[hp_C]

OpenFDA Data

SPL SET ID:68f897e3-b391-1cca-e053-2a91aa0ae21d
Manufacturer
UNII

NDC Crossover Matching brand name "Lapis albus" or generic name "Calcium Hexafluorosilicate"

NDCBrand NameGeneric Name
0220-3053Lapis albusCALCIUM HEXAFLUOROSILICATE
0220-3055Lapis albusCALCIUM HEXAFLUOROSILICATE
15631-0266LAPIS ALBUSLAPIS ALBUS
68428-468Lapis albusCALCIUM HEXAFLUOROSILICATE
71919-403Lapis albusCALCIUM HEXAFLUOROSILICATE
64117-251ITCHING SKINCALCIUM HEXAFLUOROSILICATE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.